91134-04-2Relevant academic research and scientific papers
4-Benzoylamino-3-hydroxybutyric acid, historically first "anomalous racemate": Reinvestigation
Bredikhin, Alexander A.,Bredikhina, Zemfira A.,Zakharychev, Dmitry V.,Samigullina, Aida I.,Gubaidullin, Aidar T.
supporting information, p. 1362 - 1373 (2015/05/20)
Chiral 4-benzoylamino-3-hydroxybutyric acid (1) was recognized in 1930 as the first example of "anomalous racemates" (correct to say, anomalous conglomerates), that is, specific addition compounds formed by different enantiomers in unequal ratio. Through the comparative (racemic against homochiral samples) inspection of the IR spectra, single crystal X-ray diffraction, PXRD analysis, and solubility data we have found that this substance forms normal racemic compound in the solid state, and must be excluded from the very short list of anomalous conglomerates. At the same time homo-1 is dissolved in 25 times better than rac-1, and this feature belongs to another interesting and rare type, namely, "anticonglomerates". Some of the reasons for this behavior are discussed.
Composition containing a penem or carbapenem antibiotic and the use of the same
-
, (2008/06/13)
Administration of an N-acylated amino acid in association with a penem or carbapenem antibiotic relieves or eliminates the renal problems associated with administration of the antibiotic alone. The amino acid derivative and antibiotic may be formulated together as a composition or administered separately, either simultaneously or sequentially.
Composition containing a penem or carbapenem antibiotic
-
, (2008/06/13)
Administration of an N-acylated amino acid in association with a penem or carbapenem antibiotic relieves or eliminates the renal problems associated with administration of the antibiotic alone. The amino acid derivative and antibiotic may be formulated together as a composition or administered separately, either simultaneously or sequentially. The composition may be prepared by simple mixing.
